New Kava Extract Focused on Addressing Safety Concerns
Applied Food Science has launched its new Kavoa kava extract for the relaxation, stress-relief, and sleep-support markets.
Photo © iStockphoto.com/Belitas
Safety concerns have long dogged the kava (Piper methysticum) market, but Applied Food Sciences (AFS; Austin, TX) has introduced a new kava extract that it says is produced with special concern for top safety issues surrounding kava production. Its new Kavoa kava extract is designed for the relaxation, stress relief, and sleep-support markets.
AFS told Nutritional Outlook it took several years to develop Kavoa, with the firm investigating the best methods for growing, harvesting, and processing the ingredient. That includes addressing some of the safety issues associated with kava, including use of incorrect chemotype cultivars, unstandardized harvesting practices, use of incorrect parts of the plant, inadequate manufacturing methods for producing standardized extracts, and a lack of scientifically validated methods of measurement of kava’s active components-kavalactones and chalcones.
“Working together with farmers, researchers, and agronomists, we wanted to promptly address these concerns-creating best practices to develop a better standard in kava,” said Chris Fields, vice president of scientific affairs for AFS, in the launch announcement. “From the farm level, to processing and extraction, we have implemented a six-point plan for the commercialization and sustainability of our kava supply to the nutrition market.”
AFS also recently adopted kava through the American Botanical Council’s (ABC; Austin, TX) Adopt-an-Herb program. Mark Blumenthal, founder and executive director of ABC, thanked AFS for its adoption of kava, noting it will “allow ABC to stay current with emerging research on kava’s benefits and new information that helps to clarify prior concerns about its relative safety.”
“Kava is an herb with a long ethnobotanical history in Polynesia, and it produces clinically documented anti-anxiety benefits,” Blumenthal said, in the Kavoa launch announcement. He added that ABC “also acknowledges AFS’s commitment to a robust supply-chain program that helps to ensure the sustainable harvest of the appropriate variety of kava for use in consumer products.”
Read more:
Rethinking Relaxation Ingredients with New Combinations, Product Types
Lactium Casein Hydrolysate Promotes Sleep without Sedation, Study Says
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
